Abond CRO Inc.   Report issue

For profit Phase 3
Founded: Allendale MI United States (1974)

Organization Overview

First Clinical Trial
2020
NCT04432376
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Abond CRO Inc.

Active Ingredients

Drugs in Phase 3 Trials (1)

miconazole (monistat) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Otomycosis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 1